


Healthcare Industry News: HIV/AIDS
News Release - February 13, 2007
Human Genome Sciences and GlaxoSmithKline Announce Initiation of Phase 3 Clinical Trial of LymphoStat-B(R) in Systemic Lupus Erythematosus
Source: Human Genome Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
